Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1834 of 5804
-
New dosing strategy for schizophrenia drug aims to cut side effects
Disease control Recruiting nowThe objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia
Phase: PHASE2 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 17:00 UTC
-
ALS pill trial halted: what we know about SPG302's Long-Term safety
Disease control TerminatedThis study will evaluate the long-term safety and efficacy of participants enrolled in SPG302-ALS-101 with Amyotrophic Lateral Sclerosis (ALS)
Phase: PHASE2 • Sponsor: Spinogenix • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a Plant-Based powder cut the need for IV nutrition?
Disease control Recruiting nowA 24-week, randomized, placebo-controlled, double-blind study to evaluate the efficacy, safety and tolerability of crofelemer in patients with Short Bowel Syndrome and Intestinal Failure (SBS-IF) without colon-in-continuity (CIC) requiring parenteral support (PS). Blinded study …
Phase: PHASE2 • Sponsor: Napo Therapeutics, S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New balloon method aims to stop Post-C-Section bleeding in High-Risk moms
Prevention Recruiting nowThis pilot study aims to assess performance, safety and feasibility of U-CaVIT method (Uro-Catheter Vacuum Induced Tamponade), using the Rüsch® Brillant Silicone Balloon Catheter, an urological catheter, for the prevention of atonic PPH in high-risk women undergoing cesarean deli…
Phase: NA • Sponsor: Christian Haslinger • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Bee product could tame fatty liver and blood fats
Disease control Recruiting nowMetabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver condition linked to excess body fat, high blood lipids, and other metabolic problems. Taiwan green propolis is a natural health product collected by bees from plants, which has shown potent…
Phase: NA • Sponsor: Taipei Medical University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a simple hospital program prevent PTSD in kids and parents after injury?
Symptom relief Recruiting nowPediatric traumatic injury (PTI) is a public health priority, with more than 125,000 children experiencing injuries that require hospitalization each year. These children, and their caregivers, are affected in many ways that may affect quality of life, emotional and behavioral he…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Robots and VR join the fight to recover from nerve and muscle diseases
Symptom relief Recruiting nowThe goal of this study is determine if a high-tech rehabilitation circuit is more effective than usual rehabilitation methods in improving functional outcome, particularly balance control, for patients with acute neuromuscolar diseases. The main question it aims to answer is: Ar…
Phase: NA • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Cash for Kids' brains: brazil study tests if $40 a month boosts mental health
Knowledge-focused Recruiting nowThis study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinica…
Phase: NA • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
MRNA vaccine takes on shingles: could it beat shingrix?
⭐️ VACCINE ⭐️ OngoingThe primary objective of this study is to evaluate the tolerability, reactogenicity and safety of 2 injections (approximately 2 months apart) of three different dose levels of ABO1108 in adults aged 40 years or above.
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:32 UTC
-
Mini tumors in a dish could guide breast cancer therapy
Knowledge-focused Recruiting nowThe aim of the study is to generate patient-derived organoids (PDOs) from brain resection or biopsied extra-cranial metastases. The preliminary data collected will be used to assess the ability of PDOs to predict patients' treatment response and their radio-sensitivity and chemo-…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New surgery showdown: can a gentler technique fix penile curvature better?
Disease control Recruiting nowThe goal of this clinical study is to compare two surgical techniques used for the treatment of complex Peyronie's disease. Peyronie's disease can cause penile curvature, deformity, and difficulties during sexual intercourse due to fibrotic plaques within the penile tunica albugi…
Phase: NA • Sponsor: Namik Kemal University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New mRNA vaccine targets RSV in early human trial
⭐️ VACCINE ⭐️ OngoingThe primary objective of this study is to evaluate the tolerability, reactogenicity and safety of a single injection of three dose levels of ABO1105 in adults aged 18 years or above.
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:04 UTC
-
Experimental vaccine combo aims to supercharge immune attack on bile duct cancer
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and the immune response of personalized mutant peptide vaccine with poly-ICLC adjuvant (mBTCvax) in combination with durvalumab and tremelimumab following front-line treatment in patients with advanced stage BTC.
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Gene-Guided diabetes care shows promise in new trial
Disease control OngoingThe goal of this clinical trial is to assess the efficacy of a pharmacogenetics-guided treatment, compared to standard optimized treatment, in patients with inadequately controlled type 2 diabetes. The main questions it aims to answer are: * Is the disease better controlled when…
Phase: PHASE4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sleep apnea device tracked for years in 1,000 patients
Disease control Recruiting nowThe registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.
Sponsor: Inspire Medical Systems, Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:32 UTC
-
Could a simple skin test uncover silent TB?
Diagnosis CompletedThis is an operational research in household/close contacts of confirmed TB patients to evaluate the effectiveness of C-TST compared to IGRA test in identifying latent TB cases using parameters of effectiveness and safety.
Phase: NA • Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
AI eye scanner could catch retina disease earlier
Diagnosis Recruiting nowThis study will measure how well PathFinder 1.0 detects retinal abnormalities on macular cube OCT B-scans by assessing its sensitivity and specificity.
Phase: NA • Sponsor: Carl Zeiss Meditec-Dublin CoCe • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New hope for youngest kids with rare fat disorder
Disease control TerminatedThis is an open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with generalised lipodystrophy and associated diabetes mellitus and/or hypertriglyceridaemia
Phase: PHASE3 • Sponsor: Amryt Pharma • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New MRI dye could help doctors see bladder cancer depth without surgery
Diagnosis Recruiting nowThis is a phase Ib study of the safety and performance of a novel intravesical contrast-enhanced Magnetic Resonance Imaging protocol for determination of bladder cancer stage prior to transurethral resection of bladder tumor (21 subjects) or prior to radical cystectomy for muscle…
Phase: EARLY_PHASE1 • Sponsor: Jodi Maranchie • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
A simple nudge after childbirth could transform lifelong health for moms with chronic conditions
Disease control Recruiting nowThe lack of postpartum primary care coordination is a missed opportunity to increase primary care engagement and manage chronic conditions early in life, especially for the \>30% of pregnant people who have or are at risk for these conditions. This study aims to increase postpart…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC